Bowman and Brooke Logo
Molly Jean Given

Molly Jean Given


Molly Jean Given is a trial attorney whose practice focuses on individual and mass tort product liability for a range of manufacturers including medical device, motor vehicle, and recreational vehicle. She has been a member of several trial teams taking her to Montana, Washington state, California, and a bellwether trial in Orange County, California, as part of a JCCP, with multiple defense verdicts under her belt.

Molly currently serves as lead national counsel for a medical device manufacturer.  Further, as a key team member of national counsel for multiple life sciences clients, Molly has experience developing and implementing broad defense litigation strategy and discovery practices, in addition to the daily management of cases. Molly has a deep understanding of complex regulatory issues, with vast experience that includes deposing plaintiffs' FDA expert on 510(k) compliance, developing cross examination themes and outlines, and authoring briefs to exclude these experts. She has authored and argued multiple regulatory motions and deposed dozens of medical doctors, including plaintiffs' causation experts and treating physicians. Further, Molly enjoys working with causation experts to learn the important facts behind complex theories. This helps her analyze the medical records, ask the right questions at fact witness depositions, and find common-sense ways to explain these theories to juries.

Molly began her legal career representing the firm’s “wheels” clients in automotive and recreational vehicle litigation, including working with experts on accident reconstruction and design opinions, deposing key fact witnesses, defending corporate witnesses, and implementing key defense strategy in the context of a large MDL. She finds herself again representing these clients, serving as Minnesota product liability counsel for one of the firm’s automotive clients, where she has worked on airbag non-deployment, roll over, and seat back cases. Molly truly enjoys the storytelling of trial work and working with attorneys from all the firm’s offices.


Bar Admissions

  • Minnesota, 2007

Court Admissions

  • U.S. District Court, District of Minnesota
  • U.S. District Court, Northern District of Florida
  • U.S. District Court, District of Colorado
  • U.S. District Court, Southern District of Indiana


  • University of Minnesota Law School, J.D., 2007
    magna cum laude
    Editor, Law and Inequality: A Journal of Theory and Practice
  • Colby College, B.A., 2004
    summa cum laude
    Phi Beta Kappa

Professional Associations

    • Defense Research Institute
    • Minnesota State Bar Association


    • The Legal 500
      —Named in Litigation: Product Liability Defense, Pharmaceutical/Medical Device, 2020
    • Benchmark Litigation
      —"Under 40 Hot List," 2016
    • —"Future Star," 2019 – 2020
    • Minnesota Lawyer
      —"Up & Coming Attorney," 2014
    • Super Lawyers Magazine
      —Minnesota Rising Stars, 2014 – 2020

Recent News, Events and Blogs

Speaking Engagements

  • "So You’re Going to Trial in California: A Guide to What You Need to Know," Co-Presenter, CA Life Sciences Hot Topics Seminar, April 2019
  • "Forecasting the Product Liability Landscape for Life Sciences," Co-Presenter, Client Webinar, October 2018
  • "Key Risk Considerations for Medical Device Suppliers," Co-Presenter, Client Seminar, February 2018
  • "Potential Litigation Risk Associated with Reactions to Implants Made from Resorbable Materials,” Co-Presenter, Client Seminar, October 2017
  • "Applying the Rules of Evidence: What Every Attorney Needs to Know," Electronic Discovery Update, National Business Institute, May 2012
  • "Successfully Managing eDiscovery From a Mass Tort Perspective," Co-Presenter, Client Presentaiton, February 2012


  • "From Plaintiffs' Attorneys to Congress: Using an Interdisciplinary Approach to Recalls," Co-Author, ABA Section of the Litigation, November 2014
  • "Prioritize When Deposing Plaintiff 'FDA Experts'", Author, Law 360, June 2014
  • "Concerns Heighten Over the Prospect of ‘Responsible Corporate Officer’ Prosecutions Against Drug and Device Manufacturers" Co-Author, Westlaw Journal Medical Devices, Vol. 17, Iss. 24, January 2011